What happened
Australian researchers developed BRAIx, an AI tool identifying high breast cancer risk in women with clear mammograms. Published in Lancet Digital Health, BRAIx provides a personalised risk score (0-99.9) predicting breast cancer likelihood over four years. Trained on 397,648 Australian and 4,500 Swedish mammograms, BRAIx identified 1 in 10 women in the top 2% risk group who developed cancer within four years despite clear initial screenings, proving more accurate than existing risk factors.
Why it matters
Precision risk stratification for breast cancer will shift diagnostic workflows. For healthcare procurement teams, this introduces AI tools like BRAIx that augment human perception, identifying high-risk individuals missed by traditional screening. Platform engineers must integrate systems providing personalised risk scores, enabling earlier intervention for women with clear mammograms. This follows other medical AI advancements, such as AI stethoscopes doubling valve detection, but requires human oversight for clinical context.
Subscribe for Weekly Updates
Stay ahead with our weekly AI and tech briefings, delivered every Tuesday.
